19-Nor-1,25(OH)(2)D-2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia

T Kumagai, LY Shih, Susan Hughes, JC Desmond, J O'Kelly, Martin Hewison, HP Koeffler

    Research output: Contribution to journal › Article

    38 Citations (Scopus)

    Fingerprint

    Dive into the research topics of '19-Nor-1,25(OH)(2)D-2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia'. Together they form a unique fingerprint.

    Medicine & Life Sciences